Stocklytics Platform
Asset logo for symbol NXL
Nexalin Technology
NXL48
$0.82arrow_drop_down2.70%-$0.02
Penny Stock
Asset logo for symbol NXL
NXL48

$0.82

arrow_drop_down2.70%

Performance History

Chart placeholder
Key Stats
Open$0.87
Prev. Close$0.85
EPS-0.72
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$8.67M
PE Ratio-
LOWHIGH
Day Range0.77
0.87
52 Week Range0.25
4.05
Ratios
Revenue-
EBITDA Margin %-
EPS-0.72

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Nexalin Technology (NXL)

NEXALIN TECHNOLOGY INC., a Nevada corporation (the "Company" or "Nexalin"), is an emerging growth company specializing in the development and commercialization of advanced medical devices and equipment. The Company is focused on the innovative treatment of mental health disorders through its proprietary Nexalin therapy system. Nexalin therapy is a non-invasive neuromodulation therapy that uses gentle electrical stimulation to the brain to alleviate symptoms of depression, anxiety, and insomnia.
The Nexalin therapy system has been clinically proven to effectively treat a wide range of mood and sleep disorders, including major depressive disorder, bipolar disorder, post-traumatic stress disorder, and chronic insomnia. Unlike traditional treatments such as medication and psychotherapy, Nexalin therapy is drug-free, painless, and has no known side effects. The therapy works by stimulating the production of neurotransmitters in the brain, which are chemicals that help regulate mood and sleep patterns.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Mark White
Headquarters
Houston
Employees
6
Exchange
NASDAQ
add Nexalin Technology  to watchlist

Keep an eye on Nexalin Technology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Nexalin Technology 's (NXL) price per share?

The current price per share for Nexalin Technology (NXL) is $0.83. The stock has seen a price change of -$0.02 recently, indicating a -2.71% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Nexalin Technology (NXL)?

For Nexalin Technology (NXL), the 52-week high is $4.05, which is 389.72% from the current price. The 52-week low is $0.25, the current price is 226.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Nexalin Technology (NXL) a growth stock?

Nexalin Technology (NXL) has shown an average price growth of 0.41% over the past three years. It has received a score of 93 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nexalin Technology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Nexalin Technology (NXL) stock price performance year to date (YTD)?

As of the latest data, Nexalin Technology (NXL) has a year-to-date price change of 107.63%. Over the past month, the stock has experienced a price change of -21.24%. Over the last three months, the change has been 11.1%. Over the past six months, the figure is 59.04%.
help

Is Nexalin Technology (NXL) a profitable company?

Nexalin Technology (NXL) has a net income of -$4.65M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.83K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$5.7M. Furthermore, the EBITDA is -$6.4M.
help

What is the market capitalization of Nexalin Technology (NXL)?

Nexalin Technology (NXL) has a market capitalization of $8.68M. The average daily trading volume is 182.64K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media